HealthyDirect · GrowthFit for a long SIP
JM Large Cap Fund
JM Financial Mutual FundEquity Schemes - Large Cap Fund13.8 years
The scheme seeks long term capital growth and appreciation through investment primarily in equities.
- NAV
- 181.6607
- 5 Nov 2026
- 1Y
- +0.4%
- Trailing CAGR
- AUM
- ₹355.56 Cr
- 30 Sept 2026
- Volatility
- Medium
- 13.5% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 5 Nov 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · Three-year return is above the category median.
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Buy checklist
History depth
Pass
13.8 years of path to read.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.20% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -19.8%. Ask whether you can hold through a similar fall.
Vs category
Watch
42% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Deepak Gupta · 1.8 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 32.8% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 20%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+0.4%
- 3Y+12.1%
- 5Y+10.3%
- 10Y+12.3%
- SI+12.3%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+4.7%
- 3Y+4.5%
- 5Y+10.2%
- 10Y+12.5%
- Since inception
- +12.3%
- Calendar-day CAGR
- Excess 1Y
- +1.8%
- Category median, same plan and option
- 3Y win rate
- +42%
- Windows beating the median
- 3Y percentile
- 75
- Vs comparable share classes
- SIP 3Y XIRR
- +4.5%
- Simulated monthly SIP
- Worst rolling 3Y
- +0.7%
- 2662 daily-ending windows
- Median rolling 3Y
- +14.0%
- Calendar-day CAGR
- Positive rolling 5Y
- +100%
- 2166 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -19.8%
- Worst peak-to-trough
- Current
- -4.6%
- Below last peak
- Current spell
- 769 days
- Days below latest peak
- Time below peak
- +89%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 13 days
- 149 recovered episodes
- Longest recovery
- 194 days
- Trough to prior peak
27 Sept 2024 – open
Trough 28 Feb 2025 · not recovered
-19.8%
2 Mar 2015 – 6 Sept 2016
Trough 25 Feb 2016 · recovered in 194 days
-19.5%
17 Jan 2022 – 14 Nov 2022
Trough 20 Jun 2022 · recovered in 147 days
-17.8%
17 May 2013 – 9 Dec 2013
Trough 28 Aug 2013 · recovered in 103 days
-17.3%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
75
Vs category
62
Consistency
44
Risk-adjusted
51
Drawdown
51
Mean
56
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- Three-year return is above the category median.
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 51 holdings · top 10 are 32.8%.
- Top 5
- 18.5%
- Top 10
- 32.8%
- Largest holding
- 4.6%
- Effective holdings
- 42.7
State Bank of India
Financial
4.6%
Bharti Airtel Ltd
Technology
3.9%
ICICI Bank Ltd
Financial
3.6%
Reliance Industries Ltd
Energy & Utilities
3.4%
Kotak Mahindra Bank Ltd
Financial
3.1%
What changed
DECISION
Status moved from HEALTHY to MONITOR.
27 Oct 2026
DECISION
Status moved from HEALTHY to MONITOR.
15 Sept 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
WhiteOak Capital Large Cap Fund
WhiteOak Capital Mutual Fund
- 1Y
- +0.7%
- 3Y
- +14.9%
- Vol
- 12.7%
- Max DD
- -15.2%
- Sharpe
- 0.59
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Canara Robeco Large Cap Fund
Canara Robeco Mutual Fund
- 1Y
- -1.2%
- 3Y
- +12.5%
- Vol
- 15.3%
- Max DD
- -32.6%
- Sharpe
- 0.57
- 3Y win
- +59%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Invesco India Large Cap Fund
Invesco Mutual Fund
- 1Y
- +4.5%
- 3Y
- +15.9%
- Vol
- 15.6%
- Max DD
- -36.9%
- Sharpe
- 0.61
- 3Y win
- +73%
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Axis Large Cap Fund
Axis Mutual Fund
- 1Y
- +0.7%
- 3Y
- +11.2%
- Vol
- 14.7%
- Max DD
- -30.1%
- Sharpe
- 0.56
- 3Y win
- +44%
- Higher win rate vs category
- Lower TER
Caveat: Higher volatility · Deeper drawdown · Lower trailing returns
Mahindra Manulife Large Cap Fund
Mahindra Manulife Mutual Fund
- 1Y
- -2.5%
- 3Y
- +11.2%
- Vol
- 16.4%
- Max DD
- -35.3%
- Sharpe
- 0.49
- 3Y win
- +69%
- Higher win rate vs category
- Lower TER
Caveat: Higher volatility · Deeper drawdown · Lower trailing returns